Co-Authors
This is a "connection" page, showing publications co-authored by BEENU THAKRAL and YASUHIRO OKI.
Connection Strength
0.356
-
De novo CD5+ diffuse large B-cell lymphoma, NOS: clinical characteristics and outcomes in rituximab era. Leuk Lymphoma. 2020 02; 61(2):328-336.
Score: 0.175
-
Prognostic impact of CD5 expression in diffuse large B-cell lymphoma in patients treated with rituximab-EPOCH. Eur J Haematol. 2017 Apr; 98(4):415-421.
Score: 0.145
-
CD30 expression and prognostic significance in R-EPOCH-treated patients with diffuse large B-cell lymphoma. Hum Pathol. 2017 02; 60:160-166.
Score: 0.036